van Rooijen, G
Alternative diagnoses considered included an embolic source, drug-induced, infection, or an unknown or untested coagulopathy, but were deemed less likely after extensive workup
Dec 192023API BPC 157 137525-51-0 You may like
Technical Specifications Compound: BPC-157 (Synthetic Pentadecapeptide) Format: Lyophilized peptide powder Strength: 10 mg per vial Purity: 9899% (COA included) Appearance: White lyophilized powder Category: Research peptide reagent Intended Use This product is intended strictly for: Laboratory experimentation In-vitro scientific research Biochemical and molecular studies Non-human preclinical model development Institutional or academic research programs Not intended for: Human or animal consumption Injection, ingestion, inhalation, or topical use Medical, therapeutic, diagnostic, or cosmetic purposes This compound is not approved by Health Canada, FDA, or any regulatory authority for clinical use
For example, we know 80% of Caucasian men will experience male-pattern hair loss by age 70
This period also marks the arrival of a broader next wave of players